BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18648351)

  • 21. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
    Merli G; Spyropoulos AC; Caprini JA
    Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing anemia management in hospitalized patients with end-stage renal disease.
    Heung M; Mueller BA; Segal JH
    Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
    Sundström A; Seaman H; Kieler H; Alfredsson L
    BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying cancer patients at risk for venous thromboembolism.
    Sousou T; Khorana A
    Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anemia and heart failure.
    Ghali JK
    Curr Opin Cardiol; 2009 Mar; 24(2):172-8. PubMed ID: 19532104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A; Lim LL; Tao M
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic considerations in a changing anemia environment.
    Pizzi LT
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S29-33. PubMed ID: 19010259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolic disease in autogenous breast reconstruction.
    Pannucci CJ; Chang EY; Wilkins EG
    Ann Plast Surg; 2009 Jul; 63(1):34-8. PubMed ID: 19546669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoetin delta: efficacy in the treatment of anaemia in cancer patients receiving chemotherapy.
    Krzakowski M;
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):705-13. PubMed ID: 18691854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anemia.
    Thomé S
    ACP J Club; 2008 Aug; 149(2):8. PubMed ID: 18710181
    [No Abstract]   [Full Text] [Related]  

  • 36. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
    Imberti D; Pierfranceschi MG; Falciani M; Prisco D
    Pathophysiol Haemost Thromb; 2008; 36(2):69-74. PubMed ID: 19127085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anaemia.
    Thomé S
    Evid Based Med; 2008 Oct; 13(5):149. PubMed ID: 18836117
    [No Abstract]   [Full Text] [Related]  

  • 38. New safety information for erythropoiesis-stimulating agents.
    AIDS Clin Care; 2007 May; 19(5):46. PubMed ID: 18398991
    [No Abstract]   [Full Text] [Related]  

  • 39. NONPARAMETRIC INFERENCE PROCEDURE FOR PERCENTILES OF THE RANDOM EFFECTS DISTRIBUTION IN META-ANALYSIS.
    Wang R; Tian L; Cai T; Wei LJ
    Ann Appl Stat; 2010; 4(1):520-532. PubMed ID: 25678939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review: epoetin and darbepoetin reduce need for blood transfusions but increase risk for thrombosis in patients with cancer.
    Steensma DP
    ACP J Club; 2008 Jun; 148(4):7. PubMed ID: 18588258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.